Renaissance Technologies
TSVT

Renaissance Technologies’s 2seventy bio TSVT Stock Holding History

Renaissance Technologies’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-98,839
Closed -$387K – 4146
2023
Q3 		$387K Buy
+98,839
New +$648K ﹤0.01% 2832
2023
Q2 		– Sell
-56,500
Closed -$576K – 4272
2023
Q1 		$576K Buy
56,500
+37,200
+193% +$425K ﹤0.01% 2807
2022
Q4 		$181K Buy
+19,300
New +$272K ﹤0.01% 3451

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Renaissance Technologies's TSVT Position: Q4 2023 in Review

Renaissance Technologies sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 98,839 shares — an estimated $387K sold.

Renaissance Technologies first reported a position in TSVT in Q4 2022 and held it in 3 quarters. The position peaked at $576K in Q1 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Renaissance Technologies reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 98,839 2seventy bio shares in Q4 2023, an estimated $387K.
  • Renaissance Technologies first reported a position in 2seventy bio in Q4 2022 and held it in 3 quarters.
  • Renaissance Technologies's 2seventy bio position peaked at $576K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.